APOE and Alzheimer disease: Cash et al. (2012) conducted a study that demonstrated the ability of TUDCA to reverse the efferocytosis damage induced by APOE4. In conclusion, TUDCA possesses the ability to regulate the activation of glial cells and inflammatory response caused by AD pathology. Moreover, it may exhibit an anti-inflammatory effect by restoring efferocytosis (Figure 6).